Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd share price and stock overview

Glaxosmithkline Pharmaceuticals Ltd (NSE: GLAXO, BSE: 500660) operates in the Pharmaceuticals - Multinational sector. The stock has an ISIN of INE159A01016 and a face value of Rs 10. As of 19 July 2026, it trades at Rs (2,454.80) with a market capitalisation of Rs 41590.03 crore. Figures are live and subject to change.

Glaxosmithkline Pharmaceuticals Ltd

Pharmaceuticals - Multinational
NSE BSE
2,454.80 -51.50 (-2.05%) downArrowC
As on: 19-Jul-2026 , 12:22 PM
Market Cap(₹Cr) 41590.03
Book Value(₹Cr) 132.2958859
BSE Code : 500660 NSE Symbol : GLAXO EPS(TTM) : 53.59 ISIN Demat : INE159A01016 P/E(TTM) : 45.81 Face Value(₹) : 10 Div & Yield % : 2.32

Today Market

Stock Performance

Today Market

Today's High

78,282.55

Todday's Low

77,308.00

Open at

77,370.77

Previous Close

77,186.87

Volumes

Avg Price

964.58

Historical Performance

News

06 Jul 26
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
Syngene International Ltd, Voltas Ltd, Cera Sanitaryware Ltd, Sun TV Network Ltd are among the other stocks to see a surge in volumes on BSE today, 06 July 2026.
14 May 26
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
Profit before tax was at Rs 369.12 crore in the March 2026 quarter, up 4% from Rs 354.
13 May 26
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.
13 May 26
GlaxoSmithKline Pharmaceuticals to hold AGM
GlaxoSmithKline Pharmaceuticals announced that the 101th Annual General Meeting(AGM) of the company will be held on 30 June 2026.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
17-07-26 2506.30 2510.60 2430.00 2454.80 56156 12304 137755158.90 24334.30
16-07-26 2477.10 2512.00 2466.20 2506.30 82627 12349 206890591.10 24072.75
15-07-26 2476.00 2500.90 2451.20 2483.70 49110 8072 121565078.70 24078.50
14-07-26 2420.50 2527.00 2418.30 2463.40 186910 20561 463931484.50 24052.05
13-07-26 2439.90 2439.90 2406.30 2420.50 34949 6106 84575469.30 24211.00
10-07-26 2441.00 2453.80 2423.50 2438.20 21697 5194 52966698.20 24206.90
09-07-26 2410.80 2460.80 2397.30 2440.40 71685 10479 175196354.90 23962.80
08-07-26 2399.80 2432.70 2386.20 2410.80 89722 9786 216932325.50 23882.05
07-07-26 2409.90 2415.90 2386.20 2406.50 55616 7954 133542526.60 24398.70
06-07-26 2390.20 2407.00 2370.00 2402.20 51678 12713 123454523.80 24430.35
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

41590.03

PE Ratio

45.81

PB Ratio

18.56

Dividend Yield

2.32

ROE

48.29

ROCE

58.17

Book Value (₹)

132.2958859

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 127054524 75.00 127054524 4
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127054524 75.00 127054524 4
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group 127054524 75.00 127054524 4
plus   Publice Share Holding
plus  Institution
Government(Central / State) 94 0.00 94 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 18086 0.01 11084 19
Foreign Bank 1811 0.00 1811 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8107430 4.79 8107430 242
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4689441 2.77 4689441 16
Mutual Funds / UTI 8245074 4.87 8231954 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 262315 0.15 249431 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21324251 12.59 21291245 335
plus  Non Institution
Bodies Corporate 1316774 0.78 1304678 950
Clearing Members 353 0.00 353 3
Directors & their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 881657 0.52 874813 4175
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 423852 0.25 423852 2435
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 371374 0.22 371374 12
Individuals holding nominal share capital up to Rs. 1 lakh 16932867 10.00 15854080 118143
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 39537 0.02 39537 28
Others 1060245 0.63 1060245 1
Sub Total 21027259 12.41 19929532 125748
Total Public Shareholding 42351510 25.00 41220777 126083
Total of Promoter & Public ShareHolding 169406034 100.00 168275301 126087
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 169406034 100.00 168275301 126087

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales3,821.673,749.213,453.713,251.723,278.03
OPM (%)36.2533.4827.7925.7523.41
OP1,385.391,255.19959.80837.37767.47
Other Income145.36145.93122.59100.6675.78
PBIDT1,475.191,327.98887.67903.98849.23
INTEREST2.731.311.801.812.00
PBDT1,472.461,326.67885.87902.17847.23
PBT1,426.641,264.57672.57835.43790.62
EO20.634.69-143.62-0.9711.58
PBT after EO1,406.011,259.88816.19836.40779.05
TAXES370.03332.30226.23228.76398.28
PAT1,035.98927.58589.96610.691,694.72
EPS61.1554.7634.8336.05100.04
Raw Material11.4113.3315.7913.1518.64
Power and Fuel0.790.800.860.910.85
Employee Cost15.8915.4618.0818.3018.62
Other Manufacturing Expenses1.852.192.472.272.85
Selling and Administration Expenses9.5910.2410.8511.3910.48
Miscellaneous Expenses1.461.941.972.111.77
Revenue (Growth %) 1.938.566.21-0.8012.05
PBIDT (Growth %)11.0849.60-1.806.4558.40
PAT (Growth %) 11.6957.23-3.39-63.97373.19
PBIDT (Margin %)38.6035.4225.7027.8025.91
PAT (Margin %) 27.1124.7417.0818.7851.70

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 169.41169.41169.41169.41169.41169.41
Reserves Total 2071.771779.821614.691583.592508.211327.71
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2241.181949.231784.101753.002677.621497.12
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 33.279.9518.6715.5420.0834.63
Total Debt33.279.9518.6715.5420.0834.63
Other Liabilities259.36248.40246.30254.22263.00260.29
Total Liabilities2533.812207.582049.072022.762960.701792.04
APPLICATION OF FUNDS :
Gross Block 700.21668.95683.12635.93593.89602.89
Less : Accumulated Depreciation 419.48385.31361.86305.99263.26216.00
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 280.73283.64321.26329.94330.63386.89
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress32.9314.3213.9320.3130.5013.21
Producing Properties0.000.000.000.000.000.00
Investments 1416.321142.74837.72542.78390.0924.49
Current Assets, Loans & Advances
Inventories 430.35463.17514.30437.70512.71523.34
Sundry Debtors 273.11292.55222.06192.38205.24215.60
Cash and Bank Balance1354.791400.891061.201150.732479.111157.68
Loans and Advances 93.90108.70155.08167.62108.05274.71
Total Current Assets2152.162265.301952.621948.433305.122171.33
Less : Current Liabilities and Provisions
Current Liabilities 777.26952.43806.64590.941046.53866.70
Provisions 963.85940.93692.10713.99615.36438.35
Total Current Liabilities & Provisions1741.111893.361498.741304.941661.901305.05
Net Current Assets411.05371.95453.88643.491643.22866.28
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets145.53155.99163.08151.38131.67117.24
Deferred Tax Liability11.9115.3517.1418.2018.8915.57
Net Deferred Tax133.62140.64145.94133.18112.78101.67
Other Assets259.16254.30276.33353.06453.48399.49
Total Assets2533.812207.582049.052022.762960.701792.03
Contingent Liabilities512.59453.28384.15350.59351.10485.78

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -524.24-1,544.18-561.50-769.42-737.07
Investing Activities -419.66805.1914.97-36.53385.25
Net Cash Flow -124.11-251.0532.41474.07529.60
Operating Activities 819.79487.94578.941,280.03881.42

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
RSK
Renu S. Karnad
Chairman & Non Executive Dir.
Executive
Functional Directors
BA
Bhushan Akshikar
Managing Director
MD
SW
Subesh Williams
Non Executive Director
Exec.
RB
Ronojit Biswas
Whole Time Director & CFO
Dir.
Independent Directors
MA
Manu Anand
Independent Non Exe. Director
Ind.
SM
Sunita Maheshwari
Independent Non Exe. Director
Ind.
SP
Somasundaram Palamadairamaswamy
Independent Non Exe. Director
Ind.
AW
Anup Wadhawan
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
AAN
A A Nadkarni
VP / Company Secretary / Compliance Officer
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Glaxosmithkline Pharmaceuticals Ltd? −

Glaxosmithkline Pharmaceuticals Ltd trades on NSE under GLAXO and on BSE under code 500660. The ISIN is INE159A01016 and the face value is Rs 10.

What is the share price of Glaxosmithkline Pharmaceuticals Ltd today? +

As of 19 July 2026, Glaxosmithkline Pharmaceuticals Ltd trades at Rs 2,454.80, a change of -51.50 (-2.05%) on the day. Prices are live and subject to change.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals Ltd? +

As of 19 July 2026, Glaxosmithkline Pharmaceuticals Ltd has a market cap of about Rs 41590.03 crore. This figure is live and moves with the share price.

Is Glaxosmithkline Pharmaceuticals Ltd profitable? +

In March 2026, Glaxosmithkline Pharmaceuticals Ltd reported a profit after tax of Rs 1,035.98 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Glaxosmithkline Pharmaceuticals Ltd? +

: As of 19 July 2026, the PE (TTM) for Glaxosmithkline Pharmaceuticals Ltd is 45.81 and the price-to-book ratio is 18.56. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Glaxosmithkline Pharmaceuticals Ltd pay a dividend? +

As of 19 July 2026, the dividend yield for Glaxosmithkline Pharmaceuticals Ltd is 2.32%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 75.00% of Glaxosmithkline Pharmaceuticals Ltd. Public shareholding is 25.00%, including mutual funds at 4.87% and foreign institutional investors at 4.79%.

What were the latest annual financials of Glaxosmithkline Pharmaceuticals Ltd? +

In March 2026, Glaxosmithkline Pharmaceuticals Ltd reported net sales of Rs 3,821.67 crore, revenue growth of 1.93%, and earnings per share of Rs 61.15.

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore
Trading App Screen
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web